Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice

References

• Jabs, D. A. (1992) Ocular manifestations of the rheumatic diseases. In Duane 's Clinical Ophthalmology (Ed. Tas-man, W. and Jaeger, E. A.). Pp. 1–40. Williams & Wilkins, Baltimore, MD.
   Google Scholar
• Theofilopoulos, A. N. and Dixon, F. J. (1981) Etiopatho-genesis of murine SLE. Immunologic. Rev. 55, 179–216.
   PubMed Web of Science ®Google Scholar
• Murphy, E. D. (1981) Lymphoproliferation (lpr) and other single-locus models for murine lupus. In Immuno-logic Defects in Laboratory Animals (Eds. Gershwin, M. E. and Merchant, B.). Pp. 143–172. Plenum Press, New York.
   Google Scholar
• Theofilopoulos, A. N. and Dixon, F. J. (1985) Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269–390.
   PubMed Web of Science ®Google Scholar
• Jabs, D. A., Alexander, E. L. and Green, W. R. (1985) Ocu-lar inflammation in autoimmune MRL/Mp mice. Invest. Ophthalmol. Vis. Sci. 26, 1223–1229.
   PubMedGoogle Scholar
• Jabs, D. A. and Prendergast, R. A. (1987) Reactive lym-phocytes in lacrimal gland and renal vasculitic lesions of autoimmune MRL/lpr mice express L3T4. J. Exp. Med. 166, 1198–1203.
   PubMed Web of Science ®Google Scholar
• Jabs, D. A. and Prendergast, R. A. (1988) Murine models of Sjögren's syndrome: immunohistologic analysis of dif-ferent strains. Invest. Ophthalmol. Vis. Sci. 29, 1437–1443.
   PubMed Web of Science ®Google Scholar
• Jabs, D. A., Enger, C. and Prendergast, R. A. (1991) Murine models of Sjögren's syndrome: evolution of the lacrimal gland inflammatory lesions. Invest. Ophthalmol. Vis. Sci. 32, 371–380.
   PubMed Web of Science ®Google Scholar
• Jabs, D. A. and Prendergast, R. A. (1991) Ocular inflam-mation in MRLIMp-lpelpr mice. Invest. Ophthalmol. Vis. Sci . 32, 1944–1947.
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, A. and Nagata, S. (1992) Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356, 314–317.
   Google Scholar
• Theofilopoulos, A. N., Eisenberg, R. A., Bourdon, M., Crowel, J. S., Jr. and Dixon, F. J. (1979) Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J. Exp. Med. 149, 516–534.
   Google Scholar
• Lewis, D. E., Giorgi, J. V. and Warner, N. L. (1981) Flow cytometry analysis of T cells and continuous T cell lines from autoimmune MRL/lpr mice. Nature, 289, 298–300.
   PubMed Web of Science ®Google Scholar
• Wofsy, D., Hardy, R. R. and Seaman, W. E. (1984) The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens. J. Immunol. 132, 2686–2689.
   PubMed Web of Science ®Google Scholar
• Jabs, D. A. and Prendergast, R. A. (1991) Autoimmune ocu-lar disease in MRLIMp-lpelpr mice is suppressed by anti-CD4 antibody. Invest. Ophthalmol. Vis. Sci. 32, 2718–2722.
   PubMedGoogle Scholar
• Jabs, D. A., Burek, C. L., Hu, Q., Kuppers, R. C., Lee, B. and Prendergast, R. A. (1992) Anti-CD4 monoclonal anti-body therapy suppresses autoimmune disease in MRL/ Mp-lpr/lpr mice. Cell. Immunol. 141, 496–507.
   PubMedGoogle Scholar
• Jabs, D. A., Kuppers, R. C., Saboori, A. M., Burek, C. L., Enger, C., Lee, B. and Prendergast, R. A. (1994) Effects of early and late treatment with anti-CD4 monoclonal anti-body on autoimmune disease in MRLIMp-lpelpr mice. Cell. Immunol. 154, 66–76.
   PubMedGoogle Scholar
• Jabs, D. A., Burns, W. H. and Prendergast, R. A. (1996) Paradoxical effect of anti-CD4 therapy on lacrimal gland lesions in MRLIMp-lprIlpr mice. Invest. Ophthalmol. Vis. Sci. 37, 246–250.
   PubMedGoogle Scholar
• Ledbetter, J. A. and Herzenberg, L. A. (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47, 63–90.
   PubMed Web of Science ®Google Scholar
• Ledbetter, J. A., Rouse, R. V, Micklem, H. S. and Herzen-berg, L. A. (1980) T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. J. Exp. Med. 152, 280–295.
   Google Scholar
• Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quin-tans, J., Loken, M. R., Pierres, M., Fitch, F. W. (1983) Characterization of murine T cell surface molecule, desig-nated L3T4, identified by monoclonal antibody GK-1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131, 2445–2451.
   Google Scholar
• Dialynas, D. P., Wilde, D. B., Marrack, P., Pierres, A., Wall, K. A., Havran, W., Otten, G., Loken, M. R., Pierres, M., Kappler, J. and Fitch, F. W. (1983) Characterization of the murine antigenic determinant, designated L3T4 A, rec-ognized by monoclonal antibody GK-1.5: expression of L3T4 A by functional T cell clones appears to correlate primarily with class II MHC antigen reactivity. Immunol. Rev. 74, 29–56.
   PubMed Web of Science ®Google Scholar
• Giese, T. and Davidson, W. F. (1994) Chronic treatment of C3H-lprIlpr and C3H-gldIgld mice with anti-CD8 mono-clonal antibody prevents the accumulation of double nega-tive T cells but not autoantibody production. J. Immunol. 152, 2000–2010.
   PubMed Web of Science ®Google Scholar
• Jabs, D. A., Lee, B., Burek, C. L., Saboori, A. M. and Prendergast, R. A. (1996) Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRLIMp-lprIlpr mice. Invest. Ophthalmol. Vis. Sci. 37,377–383.
   PubMed Web of Science ®Google Scholar
• Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., Matsuzawa, A., Rochelle, J. M. and Seldin, M. F. (1992) Genetic analysis of MRL-/pr mice: relationship of the Fas apoptosis gene to disease manifes-tations and renal disease-modifying loci. J. Exp. Med. 176, 1645–1656.
   PubMed Web of Science ®Google Scholar
• Steinberg, A. D., Roths, J. B., Murphy, E. D., Steinberg,R. T., and Raveche, E. S. (1980) Effects of thymectomy or androgen administration upon the autoimmune disease of MRLIMp-lprIlpr mice. J. Immunol. 125, 871–873.
   Google Scholar
• Hang, L., Theofilopoulos, A. N., Balderas, R. S., Francis, S. J. and Dixon, F. J. (1984) The effect of thymectomy on lupus-prone mice. J. Immunol. 132, 1809–1813.
   PubMed Web of Science ®Google Scholar
• Wofsy, D., Ledbetter, J. A., Hendler, P. L. and Seaman, W. E. (1985) Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134, 852–857.
   PubMed Web of Science ®Google Scholar
• Nagata, S. and Golstein, P. (1995) The Fas death factor. Science, 267, 1449–1456.
   PubMed Web of Science ®Google Scholar
• Hayashi, Y., Haneji, N., Hamano, H. and Yanagi, K. (1994) Tranfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur. Immunol., 24, 2826–2831.
   PubMed Web of Science ®Google Scholar